Nephros’ (NEPH) Speculative Buy Rating Reiterated at Benchmark

Benchmark reiterated their speculative buy rating on shares of Nephros (NASDAQ:NEPH) in a research report released on Tuesday morning,Benzinga reports. Benchmark currently has a $5.00 target price on the stock.

Nephros Price Performance

NEPH opened at $1.64 on Tuesday. The company’s 50 day simple moving average is $1.62 and its 200-day simple moving average is $1.94. Nephros has a one year low of $1.36 and a one year high of $4.04.

Institutional Investors Weigh In On Nephros

An institutional investor recently bought a new position in Nephros stock. Dimensional Fund Advisors LP acquired a new position in shares of Nephros, Inc. (NASDAQ:NEPH) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned about 0.17% of Nephros at the end of the most recent quarter. 41.10% of the stock is currently owned by hedge funds and other institutional investors.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.